SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
For Immediate Release
March, 30 2016, 11:45am EDT
Contact:
Women's Health Advocates Speak About New FDA Label Change of Medical Abortion Pill, Mifeprex
Today, the Food and Drug Administration announced the approval of an updated label for mifepristone, which is used for medical abortion. Mifepristone provides women with a safe and effective medication option for ending pregnancy. The updated labeling is more closely aligned with evidence-based medicine.
WASHINGTON
Today, the Food and Drug Administration announced the approval of an updated label for mifepristone, which is used for medical abortion. Mifepristone provides women with a safe and effective medication option for ending pregnancy. The updated labeling is more closely aligned with evidence-based medicine.
Join women's reproductive health experts to hear what this label change means for abortion providers and those seeking abortion, including in states where medical abortion is heavily restricted by state laws. More than 2.75 million women have used mifepristone as a safe option to end an early pregnancy. Despite its safety and efficacy, this drug is still unnecessarily regulated and unavailable in pharmacies. As a result, barriers to access remain.
When:
March 30, 2016
1:00 pm EST/ 10:00 am PST
Who:
* Beverly Winikoff, M.D., M.P.H., President, Gynuity Health Projects
* Carolyn Westhoff, M.D, Senior Medical Advisor, Planned Parenthood Federation of America
* Janet Crepps, Senior Counsel, Center for Reproductive Rights
* Chrisse France, Executive Director, Preterm
* Vicki Saporta, President and CEO, National Abortion Federation
Where: Audio Press Conference
Below are statements from abortion providers celebrating this change:
Amy Hagstrom Miller, President and CEO, Whole Woman's Health:
"Today's FDA announcement of a label change to Mifepristone is a significant advancement for women in the United States. All of us at Whole Woman's Health are thrilled that the updated FDA labeling reflects evidence-based care that is best for women. People who visit our clinics deserve options for abortion care without worrying about medically unnecessary obstacles and this change allows for more women to get the care they deserve.
"We are particularly encouraged that this updated labeling could expand the availability of abortion in Texas, where anti-choice politicians continue to interfere in women's personal health decisions, enacting laws such as HB2 that deny women the ability to make their own decisions about whether and when to become a parent.
"Prior to HB2, 40 to 50 percent of our patients at Whole Woman's Health chose medication abortion. Since HB2 went into effect, that figure has decreased dramatically. For the past two years only about 5 percent of the women we serve in Texas have been able to get the medication abortion care they wanted because HB2's barriers were insurmountable. This label change will dramatically expand access for women not only in Texas, but throughout our clinics nationwide.
"While we appreciate this step forward, we also acknowledge that there are still too many restrictions preventing women from quality care. The reality is that low-income women, women of color and rural women bear the brunt of abortion care restrictions. We will continue to fight for the day when all women have access to the compassionate and comprehensive reproductive health care that we provide at our clinics.
"Whole Woman's Health has a strong commitment to make medication abortion an option for all our patients and we look forward to implementing this new label change in our clinics in the coming days."
Chrisse France, Executive Director, Preterm:
"Today's FDA announcement is good news for Ohio women and families. The label change for medication abortion will mean that it will once again be a real option for Preterm's patients and women across the state. We will no longer be forced to practice medicine mandated by politicians whose ultimate goal is to shut us down. The updated label is more aligned with evidence-based medicine and has the potential to expand abortion access for Ohio women.
"In 2011, in an attempt to decrease access to abortion, politicians forced Ohio abortion providers to follow an outdated FDA protocol, under the guise of protecting women's health. In reality, this law simply made medication abortion unnecessarily costly and nearly impossible to access.
"The situation isn't perfect. Medication abortion is still being treated more restrictively than other medications. That said, we are pleased to announce that as of today we will be offering medication abortion to more women, with fewer required visits.
"Preterm is proud to have been part of the clinical trials in the 1990s that led to FDA approval of medication abortion and we look forward to offering medication abortion to a broader group of women immediately in our clinic."
LATEST NEWS
After More Private Social Security Data Exposed by Team Trump, Where Will GOP 'Draw the Line'?
"Over and over again, the Trump administration is exposing private Social Security data," said one watchdog group who called the leak of personal information "a goldmine for identity thieves" and other fraudsters.
May 03, 2026
A newly reported failure of the Trump administration's ability to handle sensitive private information within the social programs it is tasked with operating triggered a fresh wave of anger of the weekend after it came to light that the Social Security numbers of healthcare providers were made public as part of a faulty Medicare portal rollout.
The Washington Post discovered the compromised database and alerted the administration last week, before publishing a story about its discovery on Friday after efforts had been made to protect the sensitive information from further compromise.
According to the Post:
The Centers for Medicare and Medicaid Services (CMS) last year created a directory to help seniors look up which doctors and medical providers accept which insurance plans, framing it as an overdue improvement and part of the Trump administration’s initiative to modernize health care technology.
But a publicly accessible database used to populate the directory contains some of the providers’ Social Security numbers, linked to their names and other identifying information. For at least several weeks, CMS made the database available for public use as part of its data transparency efforts.
While the reporting noted that the files were "not immediately visible to users who [visited] the provider directory," lawmakers and experts said the compromised information would be a treasure trove for fraudsters.
“The more we learn about how the Trump Administration handles the people’s most sensitive data, the clearer their incompetence becomes."
Critics pounced on the new reporting, calling it "yet another mess-up by the Team Trump" and only the latest evidence that the administration cannot and should not be trusted to protect the nation's most successful anti-poverty programs or the sensitive personal data of the American people who entrust the government with that information.
"Over and over again, the Trump administration is exposing private Social Security data," said Social Security Works, an advocacy group that serves as a public watchdog for the nation's social programs.
The compromised database, said the group, "is a goldmine for identity thieves, scammers, and foreign governments. And it is undermining the very foundation of our Social Security system."
"This is a failure by this administration," said Sen. Ruben Gallego (D-Ariz.) in response to the reporting. "Exposing Social Security numbers, whether patients or providers, is unacceptable."
Rep. Richard Neal (D-Mass.), the ranking member on the House committee which overseas the Medicare program, put the onus on his Republican colleagues in Congress.
“The more we learn about how the Trump Administration handles the people’s most sensitive data, the clearer their incompetence becomes,” Neal told the Post in a statement. “Do House Republicans need to see their own data exposed before they do right by their constituents and act?”
In March, as Common Dreams reported at the time, a whistleblower filed a complaint from with the Social Security Administration accusing a former staffer with Trump's Department of Government Efficiency (DOGE), run for a time by right-wing billionaire Elon Musk, of trying to share information from SSA databases with his private employer.
Since the outset of Trump's second term, DOGE's meddling with Social Security and Trump's undermining of the program have been the source of deep anger and concerns by the program's defenders.
In a social media post on Saturday citing the whistleblower allegations from March, Rep. John Larson (D-Conn.) said, "For more than a year, 'DOGE' has been combing through the American people's records. They want to use your data to overturn elections and profit in the private sector. Enough! This administration must be held accountable for this massive data breach!"
On Friday, responding to the Post's new reporting about the compromised database of physicians' private information, Larsen condemned for Republicans for their ongoing and pervasive failures in the face of Trump's malfeasance and incompetence.
DOGE, said Larsen, "has been in your data for more than a year. We just learned that physicians' Social Security numbers were publicly exposed in an online portal launched by ‘DOGE’ officials."
"If this isn't enough for Republicans to act," he asked, "where will they draw the line?"
Keep ReadingShow Less
'The World Is Proud of You, Guido': American Peace Activist Honored in Iranian Lego Video
"Your dignity stands taller than the place you stood, and it will live forever in our memory."
May 02, 2026
Explosive Media, one of the independent outfits generating the viral videos about the war in Iran, created a short piece on Saturday to honor the American father of two who climbed atop a bridge in the Washington, DC this weekend to demand an end to the conflict.
"In honor of Guido Reichstadter, the man who climbed the Frederick Douglass Memorial Bridge to make his voice of protest heard," the group said in a post alongside the video short. "Your dignity stands taller than the place you stood, and it will live forever in our memory."
As Common Dreams reported, Reichstadter climbed the bridge wearing a t-shirt that simply read "End War" beginning on Friday afternoon, remained in protest overnight, and told one reporter he intends to remain "for a few days at least."
In honor of Guido Reichstadter,
the man who climbed the Frederick Douglass Memorial Bridge to make his voice of protest heard.
Your dignity stands taller than the place you stood,
and it will live forever in our memory. 🫡🏔️ pic.twitter.com/WANYzS7kIh
— Explosive Media (@ExplosiveMediaa) May 2, 2026
Reichstadter said he climbed the 168-foot-tall bridge “because the government of the United States is engaged in acts of mass murder in my name. And I refuse to be complicit in that.”
"The world is proud of you, Guido," Explosive Media said in a separate post on social media. "Soon, side by side, we will celebrate peace and victory together."
Keep ReadingShow Less
Mifepristone Maker Appeals to US Supreme Court Amid Fears of 'National Abortion Ban'
"The safety of mifepristone has never actually been in question," said one advocate. "As this case moves towards the US Supreme Court, we will fight until every person has access to the care they need."
May 02, 2026
A pharmaceutical company which manufactures mifepristone filed an appeal to the US Supreme Court on Saturday asking for emergency relief from the "sweeping and dangerous" lower-court ruling Friday that would prohibit the mailing of the widely used abortion medication nationwide.
Danco Laboratories, which makes the popular drug and is part of ongoing litigation stemming from a legal challenge by the Republican-controlled state of Louisiana, said Friday's ruling by the Fifth Circuit of Appeals—a decision roundly condemned by reproductive rights advocates as an attack on women's health and the right to choose across the country—will cause "tremendous uncertainty" on the "legal status of mifepristone throughout the country” if it goes into effect.
The company further argued that the ruling as it stands leaves medical providers, patients, and pharmacies “all to guess at what is allowed and what is not," whether or not abortion is legal in the state where a patient is trying to obtain it.
The company asked the nation's highest court for an immediate administrative stay to the 5th Circuit's ruling while the challenge to the drug's availability makes its way through lower courts. It also urged the Court to take up the case itself prior to the upcoming summer recess.
According to Politico:
Even a temporary disruption of access to mifepristone will have massive implications. The medication is used in nearly two-thirds of all pregnancy terminations, and a quarter of patients depend on telehealth to obtain them. The ruling also cuts off telemedicine prescription of the drug for non-abortion purposes, such as easing miscarriages.
In the wake of Friday’s ruling, medical and progressive advocacy groups stressed that doctors can still use telehealth to prescribe the other abortion pill — misoprostol. The drug can be used on its own to end pregnancies and carries fewer restrictions because it is used for an array of other purposes, including treating ulcers and stopping hemorrhages.
Skye Perryman, president and CEO of Democracy Forward who also the legal effort to make mifepristone available by mail during the COVID-19 pandemic as then-Chief Legal Officer and General Counsel of the American College of Obstetricians and Gynecologists, issued the following statement
“Women’s ability to access mifepristone through the mail or from their pharmacy has revolutionized access to care. Now, as anti-abortion extremists seek to employ their anti-abortion playbook and reverse this hard-fought victory for patients, this decision needlessly blocks people around the country from critical healthcare, discriminating in particular against those who live in rural and other areas where healthcare is inaccessible.
"Here's what is very clear: mifepristone has an OUTSTANDING safety record," said the Center for Reproductive Rights on Saturday. "It has been FDA-approved for 25 years and used by more than 7 million people."
Following Friday night's ruling by the 5th Circuit, Mini Timmaraju, president and CEO of the advocacy group Reproductive Freedom for All, said the stakes could night be higher for the right to choose in the United States.
"The court’s decision moves us one step closer to a national abortion ban," Timmaraju warned.
"It is now much more difficult for people to access abortion care," she said. "Anti-abortion politicians know their policies are unpopular, so they are using every lever of government they can. Louisiana built this case on debunked, junk science. The safety of mifepristone has never actually been in question. As this case moves towards the US Supreme Court, we will fight until every person has access to the care they need."
Keep ReadingShow Less
Most Popular